Introduction
Along with medical and technical developments, coronary care units (CCUs), established over the last 40 years, have emerged as one of the most important advances in the care of patients with acute coronary syndrome (ACS) and other cardiac emergencies (1, 2) . The key feature of these units is their ability to provide nonstop services 24 hours a day with experienced staff and advanced facilities. As CCUs became widespread, the mortality rates decreased from 30% to 5% approximately (1, 3, 4) . Apart from ACS, cardiac diseases with hemodynamic instability and conduction disorders are also treated in these units (5) (6) (7) (8) .
The purpose of this study was to provide a comprehensive evaluation of the patient profile, treatment, and outcomes of patients admitted to the CCU of a tertiary referral hospital by retrospective screening of 12-year patient records.
Methods
We examined 13,463 consecutive admissions to the CCU from 1 January 1997 through 30 June 2008. The resulting data were obtained by screening the inpatient registration database of the CCU retrospectively. Patient demographics, main admission diagnosis, cardiovascular therapies, length of CCU stay, mortality rates, and discharge status from the CCU (transfer to a clinic, other intensive care units, or to another institution for coronary angiography) were recorded.
The cases were classified as ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP) under the diagnosis of ACS. On the other hand, non-ACS diagnoses were classified as systolic heart failure, respiratory/cardiac arrest, AV block, bradycardia, atrial fibrillation, supraventricular tachycardia (SVT), ventricular tachycardia/ventricular fibrillation (VT/VF), and drug intoxication.
Statistical analysis
Statistical analysis was performed using SPSS for Windows version 15.0 (SPSS Inc., Chicago, IL, USA). Normally distributed continuous data were expressed as mean ± standard deviation (SD) and categorical variables as percentages. Normally distributed independent variables of groups were evaluated by Student's t-test, whereas abnormally distributed independent variables were evaluated by the Mann-Whitney U test. Chi square and Fisher exact tests were used for the comparison of categorical data. Data were assessed at 95% confidence interval and a P value of <0.05 was considered statistically significant.
Results
The mean age of the patients was 61 ± 13 years and the mean length of stay in the CCU was 2.3 ± 1.7 days (Table  1) . During the entire follow-up, the majority of the patients were male (66.7%); female patients were higher only in the drug intoxication group (Figure 1) .
Acute coronary syndrome accounted for 65% of all CCU admissions. In this group, the proportions of STEMI and NSTEMI/UAP were 43.4% and 21.6%, respectively. While the annual rate of patients with STEMI decreased over the years, the rate of patients with NSTEMI/UAP increased, as demonstrated in Table 2 . Among the non-ACS diagnoses, systolic heart failure (11.9%) was the most frequent, followed by respiratory/ cardiac arrest (4.6%), AV block (3.7%), atrial fibrillation (2.3%), VT/VF (2.1%), drug intoxication (1.9%), bradycardia (1.8%), and SVT (1.4%).
Thrombolytic therapy with streptokinase (STK) (38.9%), tissue plasminogen activator (tPA) (9.2%), and urokinase (0.6%) was administered to 48.7% of patients with STEMI. During the study period STK was the most administered agent compared to other thrombolytics, and was increasingly used especially after 2003. Urokinase was administered in 1998 and 1999.
When the discharge status of patients from the CCU were examined, as shown in Figure 2 , referral rates to other intensive care units or to other institutions for coronary angiography were found to have increased significantly over the years.
The average mortality rate in the CCU for the 12 years was 12.7%; it increased gradually after 2005. The average mortality rate was 10.3% before 2005 and 19.6% after 2005. The high mortality rates have a correlation with the rate of admissions to the CCU for respiratory/cardiac arrest in the same period (Figures 3 and 4) . 
Discussion
Our study is one of the largest comprehensive CCU evaluation studies, in which 13,463 patients were assessed over an extended period. Katz et al. (8) examined 29,275 patients admitted to the CCU of a tertiary care medical institution and reported long-term temporal trends in clinical characteristics, processes of care, and in-hospital outcomes. In the BLITZ-3 study (9) , where the treatment and epidemiology of patients admitted to Italian CCUs were evaluated, 6986 patients were assessed over a 14-day period. There are few reports in our country regarding this issue; in one of them Yıldız et al. (10) reported the patient profile of 2041 patients between 1998 and 2002. When the demographic characteristics of our study population were examined, similar findings were achieved in terms of sex and mean age with previous reports (9-12). The admission diagnosis of ACS (65%), mainly STEMI (43.4%), was the most common in our study. The Expanded GRACE study (11) enrolled 31,982 patients with ACS and 30% of patients were diagnosed with STEMI, 31% with NSTEMI, 26% with UAP, and the remaining 12% with another cardiac/noncardiac final diagnosis. Zobel et al. (13) reported the mortality and morbidity of the CCU in a university hospital. They found 29.8% of all patients were suffering from STEMI, 9.2% from NSTEMI, and 4.5% from UAP. According to the data of the TUMAR study (14) conducted in our country, 220,000 patients with MI were hospitalized each year; STEMI constituted 100,000 (45.4%) of these hospitalizations. Another study in our country revealed that 79% of all admissions to a tertiary center CCU were for ACS, while STEMI accounted for 47% and NSTEMI for 32% (10) .
Thrombolytic therapy was the only available reperfusion option for patients with STEMI because there was no coronary angiography laboratory in the hospital at that time. On average 48.7% of these patients received thrombolytic therapy. The first GRACE study, which covered between April 1999 and December 2000 with 11,543 patients, revealed a 65% rate of reperfusion therapy (thrombolytic or primary percutaneous therapy) in patients with STEMI (15) . Recent large-scale studies also reported a reperfusion therapy of 60%-68% in these patients (9, 11, 16) . STK (38.9%) was the most administered thrombolytic agent in our study, while tPA was used only for 9.2%, and urokinase was administered in 1998 and 1999, when the drug was available in this country. Although the relative differences of reperfusion success rates were known between thrombolytic agents, STK was used at a high rate because it was the most available thrombolytic agent in hospitals. Despite the advances in the diagnosis and treatment of ACS and non-ACS cardiac emergencies in our country, the mortality rate of 12.7% was noticeably higher than that in studies conducted in other countries. In BLITZ-3 the mortality rate of CCU was 3.3%, while it was 5.6%-8% in other large-scale studies (8, 9, 12) . There are very limited data regarding the mortality rate of CCU in this country. Yıldız et al. (10) found a rate of 9% in their study conducted in 2002.
We attribute the high mortality rate of the CCU primarily due to serving as a general intensive care unit because of the renovations within the hospital in 2006. The CCU was also a unit of the Department of Internal Medicine during the study period and besides cardiac emergencies, severe metabolic disturbances, acute respiratory failure, and drug intoxications were treated when necessary. Furthermore, during the same period of high mortality we observed an increased number of admissions with cardiac/respiratory arrest, suggesting a low rate of successful treatment of these patients. Finally, thrombolytic therapy was the only reperfusion option for patients with STEMI because there was no coronary angiography unit in the hospital and no invasive interventions could be performed. The patients who needed coronary angiography were transferred to other centers, after their acute treatment. Although cardiovascular disease was the most common cause of mortality in this country during the period of our study, there were still few centers where revascularization could be performed in the early stages of ACS.
There are several limitations of this study. Firstly, the concomitant diseases of the patients were lacking in this report, because mostly the main admission diagnosis had been recorded in the inpatient registration database of the CCU. Therefore, data regarding coexisting diseases were inadequate to be reported here. Secondly, we demonstrated the overall mortality rate of the CCU, not the mortality rates for each admission diagnosis separately. Finally, our study represents the evaluation of a single, tertiary care center during the study period, and so our results may not be generalized to other hospitals in this country.
In conclusion, we performed a comprehensive, retrospective, and annual evaluation of a tertiary care center CCU. Despite advances in diagnosis and treatment of ACS and other cardiac emergencies, the overall mortality rate of the CCU was high in our study. The possible explanations were the CCU's serving as a general intensive care unit, the low rate of successful treatment for patients with arrest, the absence of a coronary angiography unit, and the use of thrombolytic agents at lower rates. We suggest comparative studies with multicenter data including the years in which coronary revascularization has become a widely available option in routine practice.
